Morphologic properties of neoplastic mast cells: Delineation of stages of maturation and implication for cytological grading of mastocytosis

Leukemia Research

Volumn 25, Issue 7, 2001, Pages 529-536

  Sperr, Wolfgang R ^a   Escribano, Luis ^b   Jordan, John Hendrik ^a   Schernthaner, Gerit Holger ^a   Kundi, Michael ^a   Horny, Hans Peter ^c   Valent, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Classification; Disease criteria; Grading; Mast cells; Mastocytosis; Morphology

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLAST CELL; BONE MARROW; CELL COUNT; CELL GRANULE; CELL MATURATION; CELL NUCLEUS; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; MAST CELL LEUKEMIA; MORPHOLOGY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SKIN DEFECT; SURVIVAL; SYSTEMIC MASTOCYTOSIS; TUMOR CELL;

ADOLESCENT; ADULT; AGED; BONE MARROW; CELL DIFFERENTIATION; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA, MAST-CELL; LYMPHATIC DISEASES; MALE; MAST CELLS; MAST-CELL SARCOMA; MASTOCYTOSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN; SPLENOMEGALY; STAINING AND LABELING;

EID: 0034983239     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00041-8     Document Type: Article

References (35)

1. Mast cells and mast cell neoplasia: A review
2. Tissue mast cells in health and disease
3. Classification and diagnosis of mastocytosis: Current status
4. Biology, classification and treatment of human mastocytosis
5. Systemic mast cell disease. Analysis of 58 cases and literature review
6. Systemic mastocytosis: Retrospective review of a decade's clinical experience at the Brigham and Women's Hospital
7. The natural course of urticaria pigmentosa
8. Bone marrow findings in systemic mastocytosis
9. Mast cell leukemia: Report of a case and review of literature
10. Mast cell leukaemia: Evidence for bone marrow origin of the pathologic clone
11. Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis
12. Significance of systemic mast cell disease with associated hematologic disorders
13. Blood findings in generalized mastocytosis: Evidence of frequent simultaneous occurrence of myeloproliferative disorders
14. Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell disease
15. Clinical and biologic diversity of leukemias occuring in patients with mastocytosis
16. Diagnostic value of immunostaining for tryptase in patients with mastocytosis
17. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
18. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis
19. Activating and dominant inactivating c-kit catalytic domain mutations in distinct forms of human mastocytosis
20. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
21. Indolent systemic mast cell disease in adults: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications
22. Recent advances in mastocytosis research
23. Mast cell leukemia? Malignant mastocytosis with leukemia-like manifestation
24. Histomorphologische und zytologische befunde bei einem fall von gewebsmastzell-retikulose mit akutem leuämieartigem verlauf
25. Cotbiological and clinical aspects of tissue mast cell leukemia
26. A case of malignant mastocytosis with circulating mast cell precursors: Biologic and phenotypic characterization of the malignant clone
27. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American British Cooperative Group
28. Proposals for the classification of the myelodysplastic syndromes
29. The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia
30. -, colony forming cell
31. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
32. Establishment of an immature mast cell line from a patient with mast cell leukemia
33. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemia blast crisis
34. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis
35. Mast cell-lineage versus basophil luineage involvement in myeloproliferative and myelodysplastic syndromes: Diagnostic role of cell-immunophenotyping